Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edoardo Spina

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
CNS & Neurological Disorders Drug Targets|November 24, 2025
PrefaceEdoardo Spina
Expert Opinion on Drug Safety|October 31, 2007
The pharmacology and safety of paliperidone extended-release in the treatment of schizophreniaEdoardo Spina, Roberto Cavallaro
Epileptic Disorders : International Epilepsy Journal with Videotape|July 13, 2004
Antiepileptic drugs: indications other than epilepsyEdoardo Spina, Giulio Perugi
Journal of Central Nervous System Disease|July 18, 2013
Safety and efficacy of paliperidone extended-release in acute and maintenance treatment of schizophreniaEdoardo Spina, Rosalia Crupi
Rivista Di Psichiatria|October 22, 2015
Drug interactions with vortioxetine, a new multimodal antidepressantEdoardo Spina, Vincenza Santoro
Epilepsia|March 21, 2002
Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugsEdoardo Spina, Emilio Perucca
Expert Opinion on Drug Metabolism & Toxicology|May 20, 2008
Sertindole: pharmacological and clinical profile and role in the treatment of schizophreniaEdoardo Spina, Rocco Zoccali
Current Drug Metabolism|April 19, 2011
Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systemsGianluca Trifirò, Edoardo Spina
Drugs & Aging|June 1, 2002
Clinically significant drug interactions with antidepressants in the elderlyEdoardo Spina, Maria Gabriella Scordo
Pharmacogenomics|April 26, 2002
Cytochrome P450 polymorphisms and response to antipsychotic therapyMaria Gabriella Scordo, Edoardo Spina
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
CNS & Neurological Disorders Drug Targets|November 24, 2025
PrefaceEdoardo Spina
Expert Opinion on Drug Safety|October 31, 2007
The pharmacology and safety of paliperidone extended-release in the treatment of schizophreniaEdoardo Spina, Roberto Cavallaro
Epileptic Disorders : International Epilepsy Journal with Videotape|July 13, 2004
Antiepileptic drugs: indications other than epilepsyEdoardo Spina, Giulio Perugi
Journal of Central Nervous System Disease|July 18, 2013
Safety and efficacy of paliperidone extended-release in acute and maintenance treatment of schizophreniaEdoardo Spina, Rosalia Crupi
Rivista Di Psichiatria|October 22, 2015
Drug interactions with vortioxetine, a new multimodal antidepressantEdoardo Spina, Vincenza Santoro
Epilepsia|March 21, 2002
Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugsEdoardo Spina, Emilio Perucca
Expert Opinion on Drug Metabolism & Toxicology|May 20, 2008
Sertindole: pharmacological and clinical profile and role in the treatment of schizophreniaEdoardo Spina, Rocco Zoccali
Current Drug Metabolism|April 19, 2011
Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systemsGianluca Trifirò, Edoardo Spina
Drugs & Aging|June 1, 2002
Clinically significant drug interactions with antidepressants in the elderlyEdoardo Spina, Maria Gabriella Scordo
Pharmacogenomics|April 26, 2002
Cytochrome P450 polymorphisms and response to antipsychotic therapyMaria Gabriella Scordo, Edoardo Spina
Pageof 20